Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Adenocarcinoma and ERCC1[original query] |
---|
Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer research 2008 Jun 68 (12): 4928-35. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM |
Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer causes & control : CCC 2008 Dec 19 (10): 1077-83. Tse Darren, Zhai Rihong, Zhou Wei, Heist Rebecca S, Asomaning Kofi, Su Li, Lynch Thomas J, Wain John C, Christiani David C, Liu Geoffr |
Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. International journal of cancer. Journal international du cancer 2008 Jul 123 (1): 174-80. Doecke James, Zhao Zhen Zhen, Pandeya Nirmala, Sadeghi Shahram, Stark Mitchell, Green Adèle C, Hayward Nicholas K, Webb Penelope M, Whiteman David C, |
Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 2009 May 30 (5): 785-92. Pan Jennifer, Lin Jie, Izzo Julie G, Liu Yang, Xing Jinliang, Huang Maosheng, Ajani Jaffer A, Wu Xife |
Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC cancer 2009 9 (1): 439. Yin Zhihua, Zhou Baosen, He Qincheng, Li Mingchuan, Guan Peng, Li Xuelian, Cui Zeshi, Xue Xiaoxia, Su Meng, Ma Rui, Bai Weijun, Xia Shuyue, Jiang Yanduo, Xu Shun, Lv Yi, Li X |
ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females. Journal of experimental & clinical cancer research : CR 2009 28 153. Yin Zhihua, Su Meng, Li Xuelian, Li Mingchuan, Ma Rui, He Qincheng, Zhou Baos |
Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Medical oncology (Northwood, London, England) 2010 Mar . Deng Q, Sheng L, Su D, Zhang L, Liu P, Lu K, Ma S |
Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Dec 5 (12): 1933-8. Gandara David R, Grimminger Peter, Mack Philip C, Lara Primo N, Li Tianhong, Danenberg Peter V, Danenberg Kathleen |
HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population. Mutation research 2011 Aug 713 (1-2): 1-7. Yin Jiaoyang, Vogel Ulla, Ma Yegang, Qi Rong, Wang Huiwen, Yue Li, Liang Duohong, Wang Chunhong, Li Xinxin, Song Tieh |
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. BMC cancer 2011 May 11 (1): 1. Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Phillips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, Gibson MK |
DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma. Cancer 2011 Jul 117 (14): 3201-8. Han Ji-Youn, Yoon Kyong-Ah, Park Jae Hee, Lee Young Joo, Lee Geon Kook, Han Jong Hee, Yoon Sung Jin, Yun Tak, Kim Heung Tae, Lee Jin S |
Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer. Oncology letters 2012 Feb 3 (2): 415-420. Lu Hong-Yang, Su Dan, Pan Xiao-Dan, Jiang Hong, Ma Sheng-L |
ERCC1 gene +262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers. Archives of medical research 2012 Jan 43 (1): 67-74. Zhou Rong-Miao, Niu Chao-Xu, Wang Na, Chen Zhi-Feng, Lei Shu-En, Li Y |
ERCC1 intron 1 was associated with breast cancer risk. Archives of medical science : AMS 2012 Sep 8 (4): 655-8. Mojgan Hosseini, Massoud Houshmand, Ahmad Ebrahi |
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2013 Nov 82 (2): 288-93. Mazzoni Francesca, Cecere Fabiana Letizia, Meoni Giulia, Giuliani Costanza, Boni Luca, Camerini Andrea, Lucchesi Sara, Martella Francesca, Amoroso Domenico, Lucherini Elisa, Torricelli Francesca, Di Costanzo Frances |
[Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery]. Zhonghua wai ke za zhi [Chinese journal of surgery] 2012 Dec 50 (12): 1082-6. Liu Yang, Zhu Jian-quan, Zhang Lian-min, Zhang Tie-mei, Zhang Zhen-fa, Wang Chang- |
Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer. Journal of cancer research and clinical oncology 2014 Dec 140 (12): 2097-105. Deng Li-Li, Deng Hong-Bin, Lu Chang-Lian, Guo Yang, Wang Di, Yan Chun-Hua, Lv Xing, Shao Yu-X |
ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors. SpringerPlus 2015 4 327. Dumont Aurélie, Pannier Diane, Ducoulombier Agnès, Tresch Emmanuelle, Chen Jinying, Kramar Andrew, Révillion Françoise, Peyrat Jean-Philippe, Bonneterre Jacqu |
Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung. Lung cancer (Amsterdam, Netherlands) 2015 Jul 89 (1): 8-12. Lee Mi-Sun, Liu Chen-yu, Su Li, Christiani David |
Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study. Annals of surgery 2016 Nov 264 (5): 839-846. Bollschweiler Elfriede, Hölscher Arnulf H, Herbold Till, Metzger Ralf, Alakus Hakan, Schmidt Henner, Drebber Uta, Warnecke-Eberz U |
Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. Scientific reports 2017 Sep 7 (1): 10702. Zhang Ruoxin, Jia Ming, Xue Huijing, Xu Yuan, Wang Mengyun, Zhu Meiling, Sun Menghong, Chang Jianhua, Wei Qing |
Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. Scientific reports 2017 Feb 7 42185. Pintarelli Giulia, Cotroneo Chiara Elisabetta, Noci Sara, Dugo Matteo, Galvan Antonella, Delli Carpini Simona, Citterio Lorena, Manunta Paolo, Incarbone Matteo, Tosi Davide, Santambrogio Luigi, Dragani Tommaso A, Colombo Frances |
Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. BMC gastroenterology 2017 1 17 (1): 2. Cao Yongkuan, Zhang Guohu, Wang Peihong, Zhou Jun, Gan Wei, Song Yaning, Huang Ling, Zhang Ya, Luo Guode, Gong Jiaqing, Zhang L |
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia. Medical science monitor : international medical journal of experimental and clinical research 2017 Jan 23 489-497. Pilji? Burazer Marina, Mladinov Suzana, ?apkun Vesna, Kuret Sendi, Glavina Durdov Meri |
Overexpression of NEIL3 associated with altered genome and poor survival in selected types of human cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2020 5 42 (5): 1010428320918404. Tran Oanh Tn, Tadesse Serkalem, Chu Christopher, Kidane Daw |
Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer. Scientific reports 2020 12 10 (1): 21147. Casal-Mouriño Ana, Ruano-Ravina Alberto, Torres-Durán María, Parente-Lamelas Isaura, Provencio-Pulla Mariano, Castro-Añón Olalla, Vidal-García Iria, Abal-Arca José, Piñeiro-Lamas María, Fernández-Villar Alberto, Valdés-Cuadrado Luis, Barros-Dios Juan Miguel, Pérez-Ríos Móni |
TYMS 3'-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients. Pharmaceutics 2021 Dec 14 (1): . Emelyanova Marina, Pokataev Ilya, Shashkov Igor, Kopantseva Elena, Lyadov Vladimir, Heydarov Rustam, Mikhailovich Vladim |
ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia. Genes 2023 7 14 (7): . Dhouha Jamai, Raja Gargouri, Boulbaba Selmi, Abdelmajid Khab |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: